Pharma Promotion / Incidents by company / Hanmi
Hanmi
2 incidents / jurisdictions: Korea / sum of amounts reported: —
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2018 | Korea | Other | In April 2018 Hanmi was found to have violated two laws in Korea by not disclosing adverse effects of olmutinib sooner. In that month Zai said it was dropping olmutinib and a few days later Hanmi said Wikipedia: Hanmi Pharmaceutical（Controversies） | — |
| 2016 | Korea | Fine / administrative sanction | On the evening of September 29, 2016, Hanmi announced the Roche deal, causing its stock to rise; Hanmi was notified by Boehringer that evening that Boehringer was terminating their deal, and the compa Wikipedia: Hanmi Pharmaceutical（Controversies） + 1 more reports | — |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.